Jabaris S Sugin Lal, V Ananthalakshmi
Department of Pharmacology, Siddha Central Research Institute, Central Council for Research in Siddha, Ministry of AYUSH, Govt. of India, Anna Hospital Campus, Arumbakkam, Chennai, 600 106, India.
Department of Pathology, Siddha Central Research Institute, Central Council for Research in Siddha, Ministry of AYUSH, Govt. of India, Anna Hospital Campus, Arumbakkam, Chennai, 600 106, India.
Brain Behav Immun Health. 2021 Feb;11:100200. doi: 10.1016/j.bbih.2021.100200. Epub 2021 Jan 6.
The COVID-19 pandemic has now risen to a global health crisis across the globe. This novel virus outbreak has challenged India's economic, medical and public health infrastructure. Health care professionals and researchers around the world are looking for an effective treatment regime for COVID-19. The number of people infected by COVID-19 in India crossed 9.74 million; nearly eleven - months after the country reported its first case. The Ministry of Health and Family Welfare of India (MOHFW) has taken numerous measures to raise awareness on COVID-19 and the necessary actions to control the spread of the virus. The central and state governments are formulating several wartime protocols to achieve this goal. The MOHFW has implemented the new clinical management protocol to treat COVID-19. Besides, the Ministry of AYUSH has also provided guidelines to use conventional preventive and treatment strategies to enhance immunity. The national recovery rate has increased to 94.66% and the reported fatality rate is down to 1.45, due to "test, track and treat". MOHFW and Ministry of AYUSH are the two pillars of health care to prevent and manage the current pandemic outbreak in India. Since, there is no specific drug or vaccine effective against COVID-19 infection, exploring every possible option for prevention and treatment is of great importance.
新冠疫情现已演变成一场全球范围内的公共卫生危机。这种新型病毒的爆发对印度的经济、医疗和公共卫生基础设施构成了挑战。世界各地的医护人员和研究人员都在寻找针对新冠病毒的有效治疗方案。在印度报告首例病例近11个月后,该国感染新冠病毒的人数已超过974万。印度卫生和家庭福利部已采取多项措施来提高对新冠病毒的认识,并采取必要行动控制病毒传播。中央和邦政府正在制定多项战时方案以实现这一目标。卫生和家庭福利部已实施新的新冠病毒临床管理方案。此外,印度阿育吠陀部也提供了使用传统预防和治疗策略来增强免疫力的指导方针。由于采取了“检测、追踪和治疗”措施,全国康复率已升至94.66%,报告的死亡率降至1.45%。卫生和家庭福利部以及阿育吠陀部是印度预防和应对当前疫情爆发的两大医疗支柱。鉴于目前尚无针对新冠病毒感染的特效药物或疫苗,探索每一种可能的预防和治疗方案至关重要。